Latest DEF 14A proxy statements

Lixte Biotechnology Holdings, Inc. has filed a definitive proxy statement with the SEC.

WideOpenWest, Inc. announces a special stockholder meeting on December 3, 2025, for a virtual vote on its proposed acquisition by funds affiliated with DigitalBridge Investments and Crestview Partners.

Cisco Systems, Inc. has filed definitive additional proxy soliciting materials with the U.S. Securities and Exchange Commission.

Cracker Barrel outlines its strategic plan and FY2025 financial performance while defending against an activist shareholder's proxy contest.

Cisco's definitive proxy statement highlights robust fiscal 2025 financial performance, successful Splunk integration, and strategic AI investments, alongside proposals for the upcoming annual meeting.

Oil-Dri Corporation of America announces its 2025 Annual Meeting of Stockholders for December 9, 2025, to vote on director elections and auditor ratification.

Astrotech Corporation has filed definitive additional proxy soliciting materials with the SEC.

American Battery Materials, Inc. amended its 2024 Incentive Compensation Plan to continuously maintain 17.5% of outstanding shares for employee and executive incentives.

Global Crossing Airlines Group Inc. has filed a Definitive Proxy Statement with the U.S. Securities and Exchange Commission.

Espey Mfg. & Electronics Corp. announces its Annual Meeting of Shareholders on December 5, 2025, to vote on director election, auditor ratification, and executive compensation matters.

IBEX Limited's 2025 proxy statement details strong financial growth, a shift from controlled company status, and proposals for its Annual General Meeting.

Consumer Portfolio Services, Inc. will hold its annual shareholder meeting on November 19, 2025, to vote on director elections, auditor ratification, executive compensation, and a new equity incentive plan.

Cimpress PLC announces its 2025 Annual General Meeting to address director reappointments, executive compensation, share issuance authority, and auditor matters.

BrooQLy Inc. will hold its 2025 annual meeting to vote on changing its name to Dynamic Aerospace Systems Corporation, authorizing a reverse stock split, and approving two Restricted Stock Unit plans.

AutoZone details its CEO succession, board refreshment, and robust FY25 financial and operational highlights in its latest proxy statement.

CleanCore Solutions, Inc. announces its 2025 Annual Meeting of Stockholders to be held virtually on December 17, 2025, to vote on director elections and auditor ratification.

Paramount Gold Nevada Corp. announces its 2025 Annual General Meeting to address director elections, auditor ratification, executive compensation, and an amendment to its stock incentive plan.

Oil-Dri Corporation of America announces its 2025 Annual Meeting of Stockholders, highlighting strong fiscal year 2025 financial performance and proposing the election of nine directors and ratification of its independent auditor.

LightPath Technologies, Inc. announces its Annual Meeting of Stockholders to vote on director elections, executive compensation, and an increase in its stock incentive plan, alongside reporting continued net losses.

Astrotech Corporation announced its 2025 Annual Meeting of Stockholders to elect directors, ratify auditors, and address corporate governance matters, amidst increasing net losses.

Global Crossing Airlines Group Inc. announces its 2025 Annual Meeting of Stockholders to vote on director elections, reapproval of equity incentive plans, and auditor ratification.

Artificial Intelligence Technology Solutions Inc. has increased its authorized common stock by 4.5 billion shares to a total of 27.5 billion, approved by majority shareholder consent.

Clean Energy Technologies, Inc. informs shareholders of recent financing transactions totaling $651,500 through convertible notes and common stock, approved by majority stockholders to maintain NASDAQ listing.

Dynatronics Corporation has filed definitive additional proxy soliciting materials with the SEC.

Glucotrack, Inc. reminds shareholders to vote on an Equity Purchase Agreement with Sixth Borough Capital Fund at a Special Meeting on October 31, 2025.

Avidity Biosciences announces a definitive merger agreement with Novartis, spinning off its early-stage precision cardiology programs.

ENDRA Life Sciences Inc. has filed a definitive proxy statement with the SEC, outlining information required for an upcoming shareholder meeting.

STAAR Surgical Company announced the postponement of its Special Meeting for the Alcon merger vote to December 3, 2025, citing ongoing discussions.

Procaccianti Hotel REIT, Inc. will hold its 2025 Annual Meeting to re-elect directors and vote on an amendment to its advisory agreement that would remove deadlines for certain fees.

Predictive Oncology Inc. faces a "going concern" warning and seeks shareholder approval for significant equity issuance and an expanded incentive plan amidst substantial net losses and declining shareholder returns.